Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma
- 17 June 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (13), 6847-6862
- https://doi.org/10.1021/acs.jmedchem.0c00225
Abstract
Every day, hundreds of millions of people worldwide take non-steroidal anti-inflammatory drugs (NSAIDs), often in conjunction with multiple other medications. In the bloodstream, NSAIDs are mostly bound to serum albumin (SA). We report the crystal structures of equine serum albumin complexed with four NSAIDs (ibuprofen, ketoprofen, etodolac, and nabumetone) and the active metabolite of nabumetone (6-methoxy-2-naphthylacetic acid, 6-MNA). These compounds bind to seven drug-binding sites on SA. These sites are generally well-conserved between equine and human SAs, but ibuprofen binds to both SAs in two drug-binding sites, only one of which is common. We also compare binding of ketoprofen by equine SA to binding of it by bovine and leporine SAs. Our comparative analysis of known SA complexes with FDA-approved drugs clearly shows that multiple medications compete for the same binding sites, indicating possibilities for undesirable physiological effects caused by drug-drug displacement or competition with common metabolites. We discuss the consequences of NSAID binding to SA in a broader scientific and medical context, particularly regarding achieving desired therapeutic effects based on an individual’s drug regimen.Funding Information
- U.S. Department of Health and Human Services
- U.S. Department of Health and Human Services (HHSN272201200026C, HHSN272201700060C)
- U.S. Department of Health and Human Services (R01-GM117080, R01-GM118619, R01-GM132595)
This publication has 110 references indexed in Scilit:
- A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityRheumatology International, 2011
- Clinical impact of serum proteins on drug deliveryJournal of Controlled Release, 2011
- REFMAC5 for the refinement of macromolecular crystal structuresActa Crystallographica Section D-Biological Crystallography, 2011
- Overview of theCCP4 suite and current developmentsActa Crystallographica Section D-Biological Crystallography, 2011
- Features and development of CootActa Crystallographica Section D-Biological Crystallography, 2010
- Diffraction data analysis in the presence of radiation damageActa Crystallographica Section D-Biological Crystallography, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D-Biological Crystallography, 2009
- Crystallographic Analysis of Human Serum Albumin Complexed with 4Z,15E-Bilirubin-IXαJournal of Molecular Biology, 2008
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D-Biological Crystallography, 2004
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997